Female Reproductive Cancer

Reproductive malignancies are brought on by the unchecked growth and multiplication of abnormal cells that arise in the reproductive organs. Gynaecologic tumours in women are often found in the United States. 91,730 new cases are estimated to be investigated in the United States this year alone; tragically, 28,080 deaths are anticipated. The most common treatments for reproductive cancers include chemotherapy, surgery, radiation therapy, hormone therapy, or a combination of these.

Reproduction Fertility 2025 | Women Health 2025 | Reproductive Health & Fertility Assisted Reproductive Technologies (ART) | Maternal & Child Health Congress | Gynecology & Obstetrics ConferenceHormonal Imbalance & Fertility

International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG)

    Related Conference of Female Reproductive Cancer

    June 15-16, 2026

    5th World Congress on Women Health and Gynecology

    Paris, France
    August 27-28, 2026

    12th Asia Pacific Gynecology and Obstetrics Congress

    Paris, France

    Female Reproductive Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in